Trials / Sponsors / Genitope Corporation
Genitope Corporation
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment Wi Non-Hodgkin's Lymphoma | Phase 2 | 2007-05-01 |
| Terminated | A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) B-Cell Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2006-03-01 |
| Completed | Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgk Lymphoma | Phase 2 | 2003-03-01 |
| Unknown | Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Lymphoma | Phase 3 | 2000-11-01 |